Dr. Prabhleen Singh, MD

Dr. Singh practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Singh's NPI, 1235207234, was assigned on November 30, 2006. Dr. Singh graduated from N.K.P. Salve Institute Of Medical Sciences in 1999. Dr. Singh holds California license A93789.

Dr. Singh's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Singh's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Singh is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices. Vendor and product names are available with a free account.

Nephrology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Singh is board certified in nephrology by the American Board of Internal Medicine. Dr. Singh is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and kidney disease among the conditions Dr. Singh treats.

CMS data shows 243 Medicare services from Dr. Singh across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $24,030 for them. Every service was in an office.

CMS counts 131 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 45% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 62, with 42% women.

In 2024, Dr. Singh wrote 397 Medicare Part D claims for 102 patients. 82% of them were for generic drugs. CMS names the drug for 285 of them, across 10 drugs with 11 or more claims each, at $23,893 in total drug cost. In 2023, CMS named 183 claims across 8 drugs.

Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth.

Dmand AI links 20 papers to Dr. Singh, published from 2012 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Mice, Inbred C57BL, Acute Kidney Injury and Kidney. Dr. Singh has published most often in Am J Physiol Renal Physiol. Dr. Singh's most frequent co-authors are Mark L. Hepokoski, MD, Atul Malhotra, MD and Mona Alotaibi, MD.

CMS Open Payments shows 1 general payment to Dr. Singh from 1 drug or device company in 2022. Consulting fees make up the largest share, 100% of the total. Daiichi Sankyo Company LTD paid the most, $1,155.

Dr. Singh graduated from N.K.P. Salve Institute Of Medical Sciences in 1999.

Dr. Singh is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.